Effect of the NK3 receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humans
暂无分享,去创建一个
P. Whorwell | A. Zinsmeister | M. Camilleri | L. Houghton | C. Fell | A. Zinsmeister | I. Busciglio | G. Dukes | O. Dewit | F. Cremonini | D. Alpers | V. Cox | E. Gray | R. Lea | P. Whorwell | A. R. Zinsmeister | L. A. Houghton | D. H. Alpers | G. E. Dukes | P. J. Whorwell | Michael Camilleri | P. J. Whorwell | Lesley A. Houghton | Filippo Cremonini | David H. Alpers | O. E. Dewit | George E. Dukes | P. Whorwell | D. H. Alpers
[1] G. Sanger,et al. Modulation of peristalsis by NK3 receptor antagonism in guinea-pig isolated ileum is revealed as intraluminal pressure is raised. , 2007, Autonomic & autacoid pharmacology.
[2] M. Camilleri,et al. Challenges in drug development for functional gastrointestinal disorders. Part II: Visceral pain , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[3] G. Griebel,et al. Selective blockade of NK2 or NK3 receptors produces anxiolytic- and antidepressant-like effects in gerbils , 2006, Pharmacology Biochemistry and Behavior.
[4] P. Whorwell,et al. Barostat testing of rectal sensation and compliance in humans: comparison of results across two centres and overall reproducibility , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[5] M. Delvaux,et al. Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone , 1994, Digestive Diseases and Sciences.
[6] C. Maggi,et al. Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome , 2004, British journal of pharmacology.
[7] J. Furness,et al. Effects of the peripherally acting NK3 receptor antagonist, SB‐235375, on intestinal and somatic nociceptive responses and on intestinal motility in anaesthetized rats , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[8] G. Sanger. Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain , 2004, British journal of pharmacology.
[9] L. Chang,et al. Anti‐hyperalgesic effect of octreotide in patients with irritable bowel syndrome , 2004, Alimentary pharmacology & therapeutics.
[10] A. Osman,et al. The Fear of Pain Questionnaire-III: Further Reliability and Validity with Nonclinical Samples , 2002, Journal of Behavioral Medicine.
[11] W. Whitehead,et al. Standardization of Barostat Procedures for Testing Smooth Muscle Tone and Sensory Thresholds in the Gastrointestinal Tract , 1997, Digestive Diseases and Sciences.
[12] V. Plourde,et al. Role of tachykinin NK1, NK2 and NK3 receptors in the modulation of visceral hypersensitivity in the rat , 2003, Neuroscience Letters.
[13] L. Buéno,et al. Intestinal anti‐nociceptive behaviour of NK3 receptor antagonism in conscious rats: evidence to support a peripheral mechanism of action , 2003, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[14] A. Zinsmeister,et al. Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[15] S. Hsu,et al. Substance P via NK1 receptor facilitates hyperactive bladder afferent signaling via action of ROS. , 2003, American journal of physiology. Renal physiology.
[16] K. Venkova,et al. NK1 receptor-mediated mechanisms regulate colonic hypersensitivity in the guinea pig , 2003, Pharmacology Biochemistry and Behavior.
[17] A. Viera,et al. Management of irritable bowel syndrome. , 2002, American family physician.
[18] A. Doherty,et al. Pregabalin (CI-1008) inhibits the trinitrobenzene sulfonic acid-induced chronic colonic allodynia in the rat. , 2002, The Journal of pharmacology and experimental therapeutics.
[19] P. Poitras,et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. , 2002, Gastroenterology.
[20] C. Maggi,et al. Tachykinin receptor antagonists in irritable bowel syndrome. , 2002, Current opinion in investigational drugs.
[21] Y. Ikeura,et al. Effects of tachykinin NK1 receptor antagonists on the viscerosensory response caused by colorectal distention in rabbits. , 2002, The Journal of pharmacology and experimental therapeutics.
[22] U. Holzer‐Petsche,et al. Tachykinin receptors in the gut: physiological and pathological implications. , 2001, Current opinion in pharmacology.
[23] A. Zinsmeister,et al. Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[24] C. Hirshman,et al. Actin depolymerization via the beta-adrenoceptor in airway smooth muscle cells: a novel PKA-independent pathway. , 2001, American journal of physiology. Cell physiology.
[25] G. Gebhart,et al. Combinations of neurokinin receptor antagonists reduce visceral hyperalgesia. , 2001, The Journal of pharmacology and experimental therapeutics.
[26] C. Maggi,et al. A novel tachykinin NK2 receptor antagonist prevents motility‐stimulating effects of neurokinin A in small intestine , 2001, British journal of pharmacology.
[27] A. Baird,et al. Potent NK1 antagonism by SR-140333 reduces rat colonic secretory response to immunocyte activation. , 2001, American journal of physiology. Cell physiology.
[28] M. Camilleri,et al. Visceral hypersensitivity: facts, speculations, and challenges , 2001, Gut.
[29] A E Bharucha,et al. Effects of a serotonin 5-HT4 receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans , 2000, Gut.
[30] V. Théodorou,et al. Antinociceptive effect of pregabalin in septic shock-induced rectal hypersensitivity in rats. , 2000, Journal of Pharmacology and Experimental Therapeutics.
[31] R. Parker,et al. Irritable bowel syndrome patients show altered sensitivity to exogenous opioids , 2000, Pain.
[32] C. Maggi. The troubled story of tachykinins and neurokinins. , 2000, TIPS - Trends in Pharmacological Sciences.
[33] B. Naliboff,et al. A double blind parallel group pilot study of the effects of CJ-11,974 and placebo on perceptual and emotional responses to rectosigmoid distension in IBS patients , 2000 .
[34] M. Tonini,et al. Contribution of NK(2) tachykinin receptors to propulsion in the rabbit distal colon. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[35] Khan,et al. Arachidonic acid metabolites alter G protein-mediated signal transduction in heart. Effects on muscarinic K+ channels , 1990, The Journal of general physiology.
[36] Cooper,et al. 5‐HT4 receptor antagonism in irritable bowel syndrome: effect of SB‐207266‐A on rectal sensitivity and small bowel transit , 1999, Alimentary pharmacology & therapeutics.
[37] G. Gebhart,et al. Role of neurokinin 3 receptors on responses to colorectal distention in the rat: electrophysiological and behavioral studies. , 1999, Gastroenterology.
[38] T. C. Lima,et al. Naloxone-induced changes in tachykinin NK3 receptor modulation of experimental anxiety in mice , 1998, Neuroscience Letters.
[39] S. Taylor,et al. An expanded anxiety sensitivity index: evidence for a hierarchic structure in a clinical sample. , 1998, Journal of anxiety disorders.
[40] Banner,et al. SB‐207266: 5‐HT4 receptor antagonism in human isolated gut and prevention of 5‐HT‐evoked sensitization of peristalsis and increased defaecation in animal models , 1998, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[41] M. Camilleri,et al. Rectal tone, distensibility, and perception: reproducibility and response to different distensions. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[42] A. Zinsmeister,et al. Adrenergic modulation of human colonic motor and sensory function. , 1997, American journal of physiology. Gastrointestinal and liver physiology.
[43] U. Holzer‐Petsche,et al. Tachykinins in the gut. Part I. Expression, release and motor function. , 1997, Pharmacology & therapeutics.
[44] A. Zinsmeister,et al. Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon. , 1995, Gastroenterology.
[45] E A Mayer,et al. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. , 1995, Gastroenterology.
[46] J. Munakata,et al. Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. , 1994, Gastroenterology.
[47] Y. Taché,et al. Effects of the somatostatin analogue octreotide on rectal afferent nerves in humans. , 1993, The American journal of physiology.
[48] W. Hasler,et al. A somatostatin analogue inhibits afferent pathways mediating perception of rectal distention. , 1993, Gastroenterology.
[49] J. Malagelada,et al. The origin of symptoms on the brain-gut axis in functional dyspepsia. , 1991, Gastroenterology.
[50] A. Zinsmeister,et al. A patient questionnaire to identify bowel disease. , 1989, Annals of internal medicine.